文献速递慢性静脉疾病

患者对热消融与非热非肿胀性静脉曲张治疗的偏好评估

Evaluating patient preferences for thermal ablation versus nonthermal, nontumescent varicose vein treatments.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-08-11

该研究通过电子患者偏好调查,对70名成人参与者进行基于选择的联合分析,评估患者对热消融与非热非肿胀性静脉曲张治疗相关属性的偏好。结果显示,自付费用是患者最看重的属性(37.2%),市场模拟分析表明60%至80%的受访者更倾向于非热非肿胀性手术而非热消融。

要点

  • 自付费用是患者选择静脉曲张治疗时最重要的属性,占相对重要性的37.2%。
  • 患者最愿意为避免术后不适和不良事件风险付费,支付意愿分别为68.9美元和65.8美元。
  • 市场模拟显示,无论自付费用水平如何,60%至80%的受访者偏好非热非肿胀性手术而非热消融。

核心结论

  • 患者对微创静脉曲张治疗的自付费用高度敏感,市场模拟分析更倾向于非热非肿胀性手术而非热消融。

研究设计与样本

  • 研究为电子患者偏好调查,于2019年7月19日至8月13日在新泽西州三家静脉修复中心进行,共70名20岁及以上成人参与,参与率80.5%(70/87)。

主要发现

  • 在六种属性中,自付费用最重要(37.2%),其次是术后不适(17.1%)、不良事件风险(16.3%)、恢复正常活动时间(11.0%)、注射次数(10.0%)和就诊次数(8.4%)。
  • 患者为避免术后不适和不良事件风险的支付意愿最高,分别为68.9美元和65.8美元。
  • 市场模拟分析发现,无论自付费用水平如何,60%至80%的受访者偏好与非热非肿胀性手术相对应的属性组合而非热消融,且不到1%的参与者在无费用分担情况下会放弃任一治疗。

临床怎么用

  • 临床决策时应充分考虑患者对自付费用的敏感性,并告知不同治疗方式的费用差异。
  • 对于偏好非热非肿胀性手术的患者,可优先考虑相应治疗方案以提高满意度。

局限性

  • 研究样本来自新泽西州三家特定诊所,可能限制结果的普遍性。
  • 调查基于假设性治疗场景,可能与真实临床决策存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To measure patient preferences for attributes associated with thermal ablation and nonthermal, nontumescent varicose vein treatments. METHODS: Data were collected from an electronic patient preference survey taken by 70 adult participants (aged 20 years or older) at three Center for Vein Restoration clinics in New Jersey from July 19, 2019, through August 13, 2019. Survey participation was voluntary and anonymous (participation rate of 80.5% [70/87]). Patients were shown 10 consecutive screens that displayed three hypothetical treatment scenarios with different combinations of six attributes of interest and a none option. Choice-based conjoint analysis estimated the relative importance of different aspects of care, trade-offs between these aspects, and total satisfaction that respondents derived from different healthcare procedures. Market simulation analysis compared clusters of attributes mimicking thermal ablation and nonthermal, nontumescent treatments. RESULTS: Of the six attributes studied, out-of-pocket (OOP) expenditures were the most important to patients (37.2%), followed by postoperative discomfort (17.1%), risk of adverse events (16.3%), time to return to normal activity (11.0%), number of injections (10.0%), and number of visits (8.4%). Patients were willing to pay the most to avoid postoperative discomfort ($68.9) and risk of adverse events ($65.8). The market simulation analysis found that, regardless of the level of OOP spending, 60% to 80% of respondents favored attribute combinations corresponding with nonthermal, nontumescent procedures over thermal ablation, and that less than 1% of participants would forgo either treatment under no cost sharing. CONCLUSIONS: Patients are highly sensitive to OOP costs for minimally invasive varicose vein treatments. Market simulation analysis favored nonthermal, nontumescent procedures over thermal ablation.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Pappas P, Gunnarsson C, David G, et al. Evaluating patient preferences for thermal ablation versus nonthermal, nontumescent varicose vein treatments. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32791306. doi:10.1016/j.jvsv.2020.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。